Literature DB >> 27435338

A one-step duplex rRT-PCR assay for the simultaneous detection of duck hepatitis A virus genotypes 1 and 3.

Qin Hu1, Dekang Zhu2, Guangpeng Ma3, Anchun Cheng4, Mingshu Wang5, Shun Chen6, Renyong Jia7, Mafeng Liu8, Kunfeng Sun9, Qiao Yang10, Ying Wu11, Xiaoyue Chen12.   

Abstract

Duck hepatitis A virus (DHAV) is a highly infectious pathogen that causes significant bleeding lesions in the viscera of ducklings less than 3 weeks old. There are three serotypes of DHAV: serotype 1 (DHAV-1), serotype 2 (DHAV-2) and serotype 3 (DHAV-3). These serotypes have no cross-antigenicity with each other. To establish an rRT-PCR assay for the rapid detection of a mixed infection of DHAV-1 and DHAV-3, two pairs of primers and a pair of matching TaqMan probes were designed based on conserved regions of DHAV-1 VP0 and DHAV-3 VP3. Finally, we established a one-step duplex rRT-PCR assay with high specificity and sensitivity for the simultaneous detection of DHAV-1 and DHAV-3. This method showed no cross-antigenicity with the other pathogens tested, including duck plague virus, Muscovy duck parvovirus, Riemerella anatipestifer, and pathogenic E. coli from ducks. Sensitivity tests identified the minimum detection limits of this method as 98 (DHAV-1) and 10 (DHAV-3) copies/reaction. To validate the method, thirty-eight clinical samples and thirty artificially infected samples collected from dead duck embryos were studied. Thirty-seven samples were positive for DHAV-1, seventeen samples were positive for DHAV-3, and fourteen samples were positive for a mixed infection using the duplex rRT-PCR method. The method established in this study is specific, sensitive, convenient and timesaving and is a powerful tool for detecting DHAV-1, DHAV-3, and their mixed infection and for conducting surveys of pandemic virus strains.
Copyright © 2016. Published by Elsevier B.V.

Entities:  

Keywords:  DHAV-1; DHAV-3; Duck hepatitis A virus; Duplex rRT-PCR

Mesh:

Substances:

Year:  2016        PMID: 27435338     DOI: 10.1016/j.jviromet.2016.07.011

Source DB:  PubMed          Journal:  J Virol Methods        ISSN: 0166-0934            Impact factor:   2.014


  12 in total

1.  Development of an MCA-Based Real Time RT-qPCR Assay for the Simultaneous Detection and Differentiation of Duck Hepatitis A Virus Types 1 and 3.

Authors:  Chunchun Meng; Yunxiu Huang; Zaib Ur Rehman; Wen Hu; Chuanfeng Li; Ruiying Liang; Zongyan Chen; Kaijie Song; Tianchao Wei; Guangqing Liu
Journal:  Virol Sin       Date:  2020-04-08       Impact factor: 4.327

2.  Cleavage of poly(A)-binding protein by duck hepatitis A virus 3C protease.

Authors:  Di Sun; Mingshu Wang; Xingjian Wen; Anchun Cheng; Renyong Jia; Kunfeng Sun; Qiao Yang; Ying Wu; Dekang Zhu; Shun Chen; Mafeng Liu; Xinxin Zhao; Xiaoyue Chen
Journal:  Sci Rep       Date:  2017-11-24       Impact factor: 4.379

3.  Cytokine storms are primarily responsible for the rapid death of ducklings infected with duck hepatitis A virus type 1.

Authors:  Jinyan Xie; Mingshu Wang; Anchun Cheng; Xin-Xin Zhao; Mafeng Liu; Dekang Zhu; Shun Chen; Renyong Jia; Qiao Yang; Ying Wu; Shaqiu Zhang; Yunya Liu; Yanling Yu; Ling Zhang; Kunfeng Sun; Xiaoyue Chen
Journal:  Sci Rep       Date:  2018-04-26       Impact factor: 4.379

4.  Transcriptomic Characterization of a Chicken Embryo Model Infected With Duck Hepatitis A Virus Type 1.

Authors:  Jinyan Xie; Qiurui Zeng; Mingshu Wang; Xumin Ou; Yunchao Ma; Anchun Cheng; Xin-Xin Zhao; Mafeng Liu; Dekang Zhu; Shun Chen; Renyong Jia; Qiao Yang; Ying Wu; Shaqiu Zhang; Yunya Liu; Yanling Yu; Ling Zhang; Xiaoyue Chen
Journal:  Front Immunol       Date:  2018-08-24       Impact factor: 7.561

5.  DHAV-1 Inhibits Type I Interferon Signaling to Assist Viral Adaption by Increasing the Expression of SOCS3.

Authors:  Jinyan Xie; Mingshu Wang; Anchun Cheng; Xin-Xin Zhao; Mafeng Liu; Dekang Zhu; Shun Chen; Renyong Jia; Qiao Yang; Ying Wu; Shaqiu Zhang; Yunya Liu; Yanling Yu; Ling Zhang; Xiaoyue Chen
Journal:  Front Immunol       Date:  2019-04-09       Impact factor: 7.561

6.  Mutations in VP0 and 2C Proteins of Duck Hepatitis A Virus Type 3 Attenuate Viral Infection and Virulence.

Authors:  Xingjian Wen; Jinlong Guo; Di Sun; Mingshu Wang; Dian Cao; Anchun Cheng; Dekang Zhu; Mafeng Liu; Xinxin Zhao; Qiao Yang; Shun Chen; Renyong Jia; Ying Wu; Shaqiu Zhang; Sai Mao; Xumin Ou; Xiaoyue Chen; Yanling Yu; Ling Zhang; Yunya Liu; Bin Tian; Leichang Pan; Mujeeb Ur Rehman
Journal:  Vaccines (Basel)       Date:  2019-09-11

7.  The VP3 protein of duck hepatitis A virus mediates host cell adsorption and apoptosis.

Authors:  Yalan Lai; Ni Zeng; Mingshu Wang; Anchun Cheng; Qiao Yang; Ying Wu; Renyong Jia; Dekang Zhu; XinXin Zhao; Shun Chen; Mafeng Liu; Shaqiu Zhang; Yin Wang; Zhiwen Xu; Zhengli Chen; Ling Zhu; Qihui Luo; Yunya Liu; Yanling Yu; Ling Zhang; Juan Huang; Bin Tian; Leichang Pan; Mujeeb Ur Rehman; Xiaoyue Chen
Journal:  Sci Rep       Date:  2019-11-14       Impact factor: 4.379

8.  Development and evaluation of reverse transcription-insulated isothermal PCR assay to detect duck hepatitis A virus type A in liver samples using the POCKITTM system.

Authors:  Yupeng Ren; Hua Yue; Lin Zhu; Cheng Tang; Bin Zhang
Journal:  J Vet Med Sci       Date:  2019-08-12       Impact factor: 1.267

9.  Duck Hepatitis A Virus Type 1 Induces eIF2α Phosphorylation-Dependent Cellular Translation Shutoff via PERK/GCN2.

Authors:  Yuanzhi Liu; Anchun Cheng; Mingshu Wang; Sai Mao; Xumin Ou; Qiao Yang; Ying Wu; Qun Gao; Mafeng Liu; Shaqiu Zhang; Juan Huang; Renyong Jia; Dekang Zhu; Shun Chen; Xinxin Zhao; Yanling Yu; Yunya Liu; Ling Zhang; Bin Tian; Leichang Pan
Journal:  Front Microbiol       Date:  2021-04-12       Impact factor: 5.640

10.  Incompatible Translation Drives a Convergent Evolution and Viral Attenuation During the Development of Live Attenuated Vaccine.

Authors:  Xumin Ou; Mingshu Wang; Sai Mao; Jingyu Cao; Anchun Cheng; Dekang Zhu; Shun Chen; Renyong Jia; Mafeng Liu; Qiao Yang; Ying Wu; Xinxin Zhao; Shaqiu Zhang; Yunya Liu; Yanling Yu; Ling Zhang; Xiaoyue Chen; Maikel P Peppelenbosch; Qiuwei Pan
Journal:  Front Cell Infect Microbiol       Date:  2018-07-18       Impact factor: 5.293

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.